ANI Pharmaceuticals (NASDAQ:ANIP) stock rose ~11% on Monday after Q1 results beat estimates and the company raised its FY23 outlook.
Adjusted EPS climbed to $1.17, compared to adjusted loss per share of -$0.12 in Q1 2022.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased